换一批The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development.
第一作者：
Krista L,Dobo
第一单位：
Pfizer Global Research and Development, Worldwide Safety Sciences, Genetic Toxicology, Groton, CT, USA. krista.l.dobo@pfizer.com
作者：
医学主题词
药物污染(Drug Contamination);诱变力试验(Mutagenicity Tests);诱变剂(Mutagens);药用制剂(Pharmaceutical Preparations);危险性评估(Risk Assessment);构效关系(Structure-Activity Relationship)
DOI
10.1016/j.yrtph.2006.01.004
PMID
16464524
发布时间
2006-04-03
- 浏览11
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
